Pharma-Bio Serv Q1 Sales Slightly Up, Assets Top $235M

Ticker: PBSV · Form: 10-Q · Filed: Mar 17, 2025 · CIK: 1304161

Pharma-Bio Serv, Inc. 10-Q Filing Summary
FieldDetail
CompanyPharma-Bio Serv, Inc. (PBSV)
Form Type10-Q
Filed DateMar 17, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, revenue, assets

TL;DR

Pharma-Bio Serv Q1 sales $56.15M, up slightly. Assets $235.2M.

AI Summary

Pharma-Bio Serv, Inc. filed its 10-Q for the period ending January 31, 2025. The company reported net sales of $56.15 million for the first quarter of fiscal year 2025, a slight increase from the $55.94 million reported for the same period in the prior year. The company's total assets were $235.20 million as of January 31, 2025.

Why It Matters

This filing provides insight into Pharma-Bio Serv's financial performance and stability, which can influence investor decisions and market perception.

Risk Assessment

Risk Level: low — The filing indicates stable financial performance with a slight increase in sales, suggesting low immediate risk.

Key Numbers

  • $56.15M — Net Sales (Q1 2025 revenue)
  • $235.20M — Total Assets (As of January 31, 2025)
  • $22.96M — Accounts Receivable (As of January 31, 2025)

Key Players & Entities

  • Pharma-Bio Serv, Inc. (company) — Filer of the 10-Q
  • 20250131 (date) — End of reporting period
  • $56.15 million (dollar_amount) — Net sales for Q1 2025
  • $235.20 million (dollar_amount) — Total assets as of January 31, 2025

FAQ

What were Pharma-Bio Serv's net sales for the first quarter of fiscal year 2025?

Pharma-Bio Serv reported net sales of $56.15 million for the first quarter of fiscal year 2025.

What was the total amount of Pharma-Bio Serv's assets as of January 31, 2025?

As of January 31, 2025, Pharma-Bio Serv's total assets amounted to $235.20 million.

How do the Q1 2025 net sales compare to the same period in the prior year?

The filing indicates net sales of $56.15 million for Q1 2025, a slight increase from the prior year's comparable period.

What is the company's Standard Industrial Classification (SIC) code?

Pharma-Bio Serv, Inc. is classified under SIC code 8742, SERVICES-MANAGEMENT CONSULTING SERVICES.

When was Pharma-Bio Serv, Inc. formerly known as?

The company was formerly known as LAWRENCE CONSULTING GROUP INC, with a name change date of September 23, 2004.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on March 17, 2025 regarding Pharma-Bio Serv, Inc. (PBSV).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.